CMS Eyes Expedited Pathway to Medicare Coverage of Innovative Tech

CMS Eyes Expedited Pathway to Medicare Coverage of Innovative Tech

Federal officials are proposing an expedited pathway for Medicare coverage of new medical technologies. In a notice posted in the Federal Register, the Centers for Medicare & Medicaid Services (CMS) is proposing a voluntary Transitional Coverage for Emerging Technologies (TCET) pathway for designated Breakthrough Devices. Officials say the new pathway, developed in a partnership with the Agency for Healthcare Research and Quality (AHRQ), should speed up the process to bring new treatments to Medicare beneficiaries while ensuring those treatments still meet rigorous review guidelines.

Medigy Insights

The Centers for Medicare & Medicaid Services (CMS) have introduced a voluntary Transitional Coverage for Emerging Technologies (TCET) pathway, as outlined in a notice published in the Federal Register. This pathway, established in collaboration with the Agency for Healthcare Research and Quality (AHRQ), aims to expedite Medicare coverage of designated Breakthrough Devices. By implementing this pathway, officials anticipate accelerated access to novel treatments for Medicare beneficiaries, while upholding stringent review standards to ensure treatment efficacy and safety.


Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on May 13, 2024 at 3:24pm